arrow
A

Alessio Amatu

university of milan
H指数:42
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Management of Increasing Complexity of Phase I Trials: A Retrospective Analysis from the Niguarda Cancer Center Phase I Unit

管理I期临床试验日益增加的复杂性:来自Niguarda癌症中心I期单位的回顾性分析

2026-02-010
PRE
Total neoadjuvant therapy followed by non-operative management or surgery in stage II–III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial

总新辅助治疗继之以非手术治疗或手术治疗的II~III期直肠癌(NO-CUT):一项多中心、单臂、II期临床试验

2025-11-240
PRE
Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies

靶向HER2在转移性结直肠癌中的应用:当前疗法、生物标志物优化及新兴策略

Drugs
IF14.4
2025-11-170
OAAI
Impact of chemotherapy on humoral and cellular immune responses to COVID-19 vaccination in patients with solid tumors

化疗对实体瘤患者对COVID-19疫苗接种的体液和细胞免疫反应的影响

2025-09-260
OAAI
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection

甲基BEAMing和液滴数字PCR检测MGMT基因启动子甲基化的比较研究

2024-11-050
OA
Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO)

奥希替尼在具有罕见表皮生长因子受体突变的非小细胞肺癌中的活性: 回顾性观察性多中心研究 (ARTICUNO)

2024-06-011
OAAI
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Divarasib联合西妥昔单抗治疗KRAS G12C-positive结直肠癌: 1b期临床试验

2023-12-0531
OAAI
A Phase 1/1b study of KAZ954 alone and in combination with spartalizumab (PDR001) and taminadenant (NIR178) in patients with advanced gastrointestinal malignancies
2023-12-010
PRE
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer

循环肿瘤DNA驱动转移性结直肠癌的治疗

2023-07-128
OAAI
Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer ( vol 12, 1030232, 2022)

病例报告: MAP2K1 K57N突变与转移性结直肠癌抗EGFR单克隆抗体原发性耐药相关 (第12卷,1030232,2022)

2023-03-282
OAAI
Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer

病例报告: MAP2K1 K57N突变与转移性结直肠癌抗EGFR单克隆抗体原发性耐药相关

2022-11-074
OAAI
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial

循环肿瘤DNA指导帕尼单抗在转移性结直肠癌中的再攻击: CHRONOS 2期试验

2022-08-01119
OAAI
Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients

替莫唑胺治疗可改变错配修复并增加结直肠癌患者肿瘤和血液中的突变负荷

2022-05-0663
OAAI